Phase 1, Open-label, Fixed Sequence, 2-period Study To Investigate The Effect Of Multiple Doses Of Itraconazole On The Pharmacokinetics Of Single Dose Pf-06463922 In Healthy Volunteers In The Fasted Condition
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs Lorlatinib (Primary) ; Itraconazole
- Indications Neuroblastoma; Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 12 May 2017 Status changed from recruiting to completed.
- 16 Dec 2016 Planned number of patients changed from 12 to 16.
- 10 Nov 2016 Planned End Date changed from 1 Jan 2017 to 1 Apr 2017.